United Therapeutics Corp (UTHR)
237.96
+0.92
(+0.39%)
USD |
NASDAQ |
Apr 19, 16:00
237.96
0.00 (0.00%)
After-Hours: 19:42
United Therapeutics Cash from Investing (Quarterly): 42.10M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 42.10M |
| September 30, 2023 | -313.40M |
| June 30, 2023 | -227.20M |
| March 31, 2023 | -221.10M |
| December 31, 2022 | -189.30M |
| September 30, 2022 | -94.00M |
| June 30, 2022 | -169.00M |
| March 31, 2022 | -359.20M |
| December 31, 2021 | -195.80M |
| September 30, 2021 | -235.90M |
| June 30, 2021 | -48.90M |
| March 31, 2021 | -6.30M |
| December 31, 2020 | -63.80M |
| September 30, 2020 | -271.70M |
| June 30, 2020 | -375.40M |
| March 31, 2020 | -27.60M |
| December 31, 2019 | 66.20M |
| September 30, 2019 | -298.70M |
| June 30, 2019 | -42.60M |
| March 31, 2019 | -60.30M |
| December 31, 2018 | -72.20M |
| September 30, 2018 | -329.90M |
| June 30, 2018 | -359.80M |
| March 31, 2018 | -58.70M |
| December 31, 2017 | -278.40M |
| Date | Value |
|---|---|
| September 30, 2017 | -200.20M |
| June 30, 2017 | -191.40M |
| March 31, 2017 | -165.60M |
| December 31, 2016 | 8.50M |
| September 30, 2016 | 20.10M |
| June 30, 2016 | 7.70M |
| March 31, 2016 | 12.00M |
| December 31, 2015 | 56.50M |
| September 30, 2015 | 347.60M |
| June 30, 2015 | 31.10M |
| March 31, 2015 | 68.40M |
| December 31, 2014 | 51.99M |
| September 30, 2014 | 97.95M |
| June 30, 2014 | 82.18M |
| March 31, 2014 | 106.38M |
| December 31, 2013 | -156.35M |
| September 30, 2013 | -175.82M |
| June 30, 2013 | 26.57M |
| March 31, 2013 | 10.64M |
| December 31, 2012 | -164.70M |
| September 30, 2012 | 47.61M |
| June 30, 2012 | -0.287M |
| March 31, 2012 | -45.99M |
| December 31, 2011 | 16.18M |
| September 30, 2011 | -57.96M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-375.40M
Minimum
Jun 2020
66.20M
Maximum
Dec 2019
-159.56M
Average
-189.30M
Median
Dec 2022
Cash from Investing (Quarterly) Benchmarks
| Liquidia Corp | -0.206M |
| Esperion Therapeutics Inc | 0.00 |
| Vertex Pharmaceuticals Inc | -886.50M |
| Sarepta Therapeutics Inc | -64.36M |
| Heron Therapeutics Inc | -8.836M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 150.70M |
| Cash from Financing (Quarterly) | -92.80M |
| Free Cash Flow | 747.60M |
| Free Cash Flow Per Share (Quarterly) | 1.44 |
| Free Cash Flow to Equity (Quarterly) | 172.00M |
| Free Cash Flow to Firm (Quarterly) | 72.00M |
| Free Cash Flow Yield | 6.32% |